At Coral Drugs, manufacturing excellence is more than technology, it’s a synergy of people, process, and precision. Every stage, from R&D to commercial production, reflects our dedication to scientific advancement, regulatory compliance, and sustainable operations.

The journey begins at our Research & Development (R&D) centre, where chemical and analytical scientists collaborate to transform ideas into viable processes. Our CRD team designs the synthesis pathway, while ARD ensures analytical integrity through rigorous method development and validation. These efforts ensure each API is built on a foundation of data-driven process control and regulatory alignment with global pharmacopoeias such as USP, EP, and IP.

From laboratory success, the process scales up through our pilot production units, where reproducibility, yield, and stability are evaluated. Each step undergoes validation and long-term stability testing to ensure consistent quality a critical requirement for global regulatory submissions. Once proven at pilot scale, the process moves seamlessly into commercial production, supported by facilities equipped with advanced engineering controls and GMP compliance.

Our state-of-the-art plant reflects Coral’s technological depth. Facilities are equipped for reactions across temperature extremes from cryogenic (-40°C) to high-heat (+200°C) and specialized operations like hydrogenation, condensation, and hydrolysis. Controlled crystallisation ensures precise polymorph control, while jet milling and micronization technologies deliver optimal particle size distribution, improving bioavailability and formulation compatibility. Every operation takes place under carefully monitored HVAC systems with bio-burden control to safeguard product integrity.

A hallmark of Coral Drugs’ manufacturing philosophy is vertical integration. By developing certain key starting materials (KSMs) and intermediates in-house, we maintain control over quality, timelines, and compliance. This internal capability reinforces supply chain resilience and enhances traceability a critical differentiator in global API manufacturing.

Our excellence extends beyond production into quality and sustainability. A robust Quality Management System (QMS) ensures documentation integrity, cleaning validation, and continuous process monitoring. Our QC and microbiology laboratories are equipped to test APIs, water systems, and environmental samples, maintaining stringent compliance. Meanwhile, our Effluent Treatment Plant (ETP) ensures all emissions meet international environmental standards, reaffirming our commitment to responsible manufacturing.

At Coral Drugs, our story is told not only through molecules but also through the people behind them. Every process engineer, analyst, and quality expert contributes to our mission of delivering safe, compliant, and effective APIs to markets worldwide. This human element paired with our technological strength defines the Coral difference.

Follow Coral Drugs on LinkedIn to see how we’re shaping the future of pharmaceutical manufacturing.

‍